Giudicelli et al. found that RYGB enhances metabolic health and diabetes outcomes in both young and older non-insulin-dependent diabetic adults, emphasizing the importance of timely surgery for better glycemic control and reduced cardiovascular risk [10]. The gene discussed is INS; the disease is diabetes mellitus.